Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Larry Alphs, MD, PhD: Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale
1
x
$
30.00
Oncology Spectrums: Volume 2 No. 6
1
x
$
0.00
The Addition of Amphetamine to Potentially Sedating Medication Regimens: An Exploratory Investigation of the Impact upon Reaction Time and Sustained Attention
1
x
$
30.00
Statistical Strategies for Randomized Controlled Clinical Trials to Detect Differential Onset of Action
1
x
$
30.00
Ellen B. Dennehy, PhD: Concordance with Treatment Guidelines for Bipolar Disorder: Data from the Systematic Treatment Enhancement Program for Bipolar Disorder
1
x
$
30.00
Psychopharmacology Bulletin VOL 48 No. 1, 2018 - Full Issue Stacked PDF
1
x
$
90.00
Oncology Spectrums: Volume 2 No. 9
1
x
$
0.00
A Pilot Controlled Trial of Bupropion XL Versus Escitalopram in Generalized Anxiety Disorder
1
x
$
30.00
Michael E. Thase, MD: Editor's Letter
1
x
$
0.00
Carol Vidal Castro, MD - Reboxetine: An Alternative for Induced Bruxism
1
x
$
30.00
Theodore J. Anfinson, MD: Drug Dependence Involving Prednisone:Two Cases and a Review of the Literature
1
x
$
30.00
Laura Cousino Klein, PhD: Smoking Abstinence Impairs Time Estimation Accuracy in Cigarette Smokers
1
x
$
30.00
David V. Sheehan, MD, MBA: Current Approaches to the Pharmacologic Treatment of Anxiety Disorders
1
x
$
30.00
Influence of Plasma Concentration of Hsa-Mir-370-3p and Cyp2d6*4 On Equilibrium Concentration of Phenazepam in Patients with Recurrent Depressive Disorder
1
x
$
30.00
Going Virtual During a Pandemic: An Academic Psychiatry Department’s Experience with Telepsychiatry
1
x
$
30.00
Ahmad Ghanizadeh - Does Risperidone Improve Hyperacusia in Children with Autism?
1
x
$
30.00
E. Chris Muly, MD, PhD: Signal Transduction Abnormalities in Schizophrenia: the cAMP System
1
x
$
30.00
Nienke Dekker, MD: Cessation of Cannabis Use by Patients with Recent-Onset Schizophrenia and Related Disorders
1
x
$
30.00
Guest Editor: Research Needs in Myeloma
1
x
$
0.00
Betty Jo Salmeron, MD: Pharmacological Applications of Magnetic Resonance Imaging
1
x
$
30.00
Ahmad Ghanizadeh, MD: Photophobia and Methylphenidate
1
x
$
30.00
Fabiana da Silva Alves, MS: The Revised Dopamine Hypothesis of Schizophrenia: Evidence from Pharmacological MRI Studies with Atypical Antipsychotic Medication
1
x
$
30.00
A Phase 2 Open Label Study of Efficacy, Safety, and Tolerability of SLS-002 (Intranasal Racemic Ketamine) in Adults with MDD at Imminent Risk of Suicide
1
x
$
30.00
Impact of the Omics-Based Biomarkers on the Fluvoxamine’s Steady-State Concentration, Efficacy and Safety in Patients with Affective Disorders Comorbid with Alcohol Use Disorder
1
x
$
30.00
Top-Up Clozapine for Risperidone LAI-Related Acute Dystonia and TR Bipolar in an Adolescent with ID-Putting the Cart before the Horse?
1
x
$
30.00
Quetiapine XR Negative Clinical Trials Report by Gang Wang
1
x
$
30.00
View Cart
Checkout
Home
quetiapine-xr
“Quetiapine XR Negative Clinical Trials Report by Gang Wang” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
A Randomized, Placebo-Controlled Pilot Study of Quetiapine-XR Monotherapy or Adjunctive Therapy to Antidepressant in Acute Major Depressive Disorder with Current Generalized Anxiety Disorder
$
30.00
Add to cart
Details
Quetiapine XR Negative Clinical Trials Report by Gang Wang
$
30.00
Add to cart
Details
Page load link
Go to Top
